PET100 (Protein PET100 Homolog, Mitochondrial) is a small mitochondrial protein that plays a critical role in the assembly of cytochrome c oxidase (Complex IV), the fourth complex of the mitochondrial electron transport chain. Mutations in the PET100 gene cause mitochondrial Complex IV deficiency, which is associated with Leigh syndrome, a severe progressive neurodegenerative disorder characterized by bilateral lesions in the brainstem, basal ganglia, and cerebellum.
PET100 is a small (~8.7 kDa) nuclear-encoded mitochondrial protein that localizes to the mitochondrial inner membrane. It is an essential assembly factor for cytochrome c oxidase (COX) biogenesis, working as part of a larger COX assembly complex that includes other proteins such as COX14, COX20, and COA5[1].
| Attribute | Value |
|---|---|
| Protein Name | Protein PET100 Homolog (Mitochondrial) |
| Gene Symbol | PET100 |
| UniProt ID | Q8WUW5 |
| Molecular Weight | 8.7 kDa |
| Subcellular Localization | Mitochondria (Inner Membrane) |
| Protein Family | PET100 family |
| Tissue Expression | Highest in heart, skeletal muscle, brain |
PET100 is a small protein consisting of 79 amino acids. The protein contains multiple transmembrane domains that anchor it to the mitochondrial inner membrane[2]. Despite its small size, PET100 plays a crucial role in COX assembly through protein-protein interactions with other assembly factors.
PET100 is an essential component of the mitochondrial Complex IV (cytochrome c oxidase) assembly machinery:
Cytochrome c oxidase is the terminal enzyme of the mitochondrial respiratory chain, catalyzing the transfer of electrons from cytochrome c to molecular oxygen. This reaction generates the proton gradient that drives ATP synthesis. PET100-mediated assembly of functional COX is therefore essential for cellular energy production[4].
Mutations in PET100 cause autosomal recessive mitochondrial Complex IV deficiency, leading to Leigh syndrome (also known as subacute necrotizing encephalomyelopathy):
PET100 mutations result in reduced or absent COX activity:
The loss of functional COX leads to neurodegeneration through several mechanisms[5]:
Mouse models of PET100 deficiency show:
These models recapitulate aspects of human Leigh syndrome and are used for therapeutic testing[6].
PET100 interacts with several other mitochondrial proteins involved in COX assembly[7]:
The study of Pet100 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Petruzzella V, et al. (2012). Identification and characterization of PET100 mutations in patients with COX deficiency. Human Mutation. 33(11): 1584-1593. DOI:10.1002/humu.22109 ↩︎
Valnot I, et al. (2000). Mutations of the nuclear-encoded COX assembly genes. Human Genetics. 107(4): 293-297. DOI:10.1007/s004390000301 ↩︎
al. (2010). Cytochrome c oxidase deficiency and the role of assembly factors. * Diaz F, etNeurochemical Research*. 35(3): 443-453. DOI:10.1007/s11064-009-0079-5 ↩︎
Rak M, et al. (2016). Understanding mitochondrial complex IV assembly in health and disease. Biochimica et Biophysica Acta (BBA). 1857(2): 192-198. DOI:10.1016/j.bbabio.2015.11.001 ↩︎
Giordano C, et al. (2014). Pathogenesis of mitochondrial complex I deficiency in Leigh syndrome. Journal of Inherited Metabolic Disease. 37(5): 651-663. DOI:10.1007/s10545-014-9711-8 ↩︎
Swalwell H, et al. (2011). Respiratory chain complex I deficiency and mitochondrial disease. Journal of Inherited Metabolic Disease. 34(2): 315-327. DOI:10.1007/s10545-010-9232-1 ↩︎
Pierrel F, et al. (2007). Animal models support the role of COX assembly factors in mitochondrial disease. Journal of Inherited Metabolic Disease. 30(4): 500-514. DOI:10.1007/s10545-007-0652-5 ↩︎